(1 year, 3 months ago)
Lords ChamberThe hope is that there will be two effective and cost-effective vaccines, nirsevimab and the Pfizer maternal jab. Those are much more effective and give longer periods of protection than the current monthly jab—they give six months’ protection. They are open to a mass campaign, particularly for young children, who are the most at-risk group. That allows us to have a negotiation with both parties with some healthy competitive tension so that we can get the best price, because we know that either one will do the job quite well. Where we can reach a successfully negotiated outcome, we hope that will set us up either to do either a year-round programme, if it really is very cost effective, or, if it is still quite expensive, to focus on the winter months, because that is the time when young children are most at risk if they have just been born. Those negotiations are live, and I will be happy to update the House as we learn more.
My Lords, I, too, welcome the Minister’s detailed knowledge of this subject. Testing it even further, if I may, can I ask him whether His Majesty’s Government have made any assessment of the usefulness of glycolipid research in countering not only RSV but other viral illnesses, including influenza and Covid-19?
I fear I might have been taken to the limit of my knowledge. I would like to think I know when to stop and to offer to follow up in writing.
(1 year, 7 months ago)
Lords ChamberI think we all agree that the mental health and well-being of everyone in society is paramount. At the same time, I would hope that junior doctors did not feel the need to take this action. As I say, in other areas relating to Agenda for Change we have reached a good outcome. We sat down with the BMA junior doctors committee hoping to have the same constructive conversations around settlements that we had already reached, but unfortunately that was not forthcoming. So my main response to concerns in that space is this: please do not strike. Please sit down with us again and engage constructively.
My Lords, we know that a major cause of the strikes that we have recently seen in the health service relates to staff who are overstretched. That is the result of chronic shortages, which suggests a lack of adequate workforce planning. We have just heard that there are currently over 124,000 reported vacancies, according to the NHS Confederation. I repeat a question that was asked earlier, or shall at least reinforce it: when will the workforce plan be published? Without it, healthcare staff will continue to struggle to provide the level of care that they would like.
As I have mentioned many a time and am happy to mention again, the workforce plan will be announced shortly—soon. I wish I could give an exact date, but it is there. However, I am sorry to say that I do not believe that can be used as an excuse for the strike action that we are talking about now, which puts patients at risk. I know that, in other areas, the Agenda for Change unions have worked constructively with NHS trusts on derogations to protect patients, but I regret to inform the House that that is not the case now. There is lots that we need to do in the workforce space, and there is lots that we want to do around recruitment, motivation and making it a good place to work, but I would like to think that none of that means that the delay of a report is a reason to take this sort of action and put patients’ lives in danger. I do not think any of us would agree that that is a suitable reason.
(1 year, 9 months ago)
Lords ChamberI agree. There are many examples of where centrally run initiatives did not work so well, test and trace being one. That is what the inquiry is all about. There are many examples of things that worked very well, such as our vaccine preparation and our creating the first test for Covid, through the PCR process. There are many lessons to learn, including from many of these centrally run initiatives.
My Lords, can the Minister tell us whether His Majesty’s Government have yet put in place a revised system to purchase PPE during a pandemic?
PPE is an example of where we all agree that we could have done better, to say the least. At this stage, I should declare an interest in that I set up a Covid testing company—not PPE—which never supplied the Government. I want to be clear about that, so that the House is fully aware of it in terms of my replies, now we are talking about PPE and related areas. Yes, we can learn a lot about PPE. At the same time, we did buy 35 billion items, 97% of which worked very well. It is important that we keep all this in context; we got 97% of things right.